Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2005
Authors:
Skarlos, Dimosthenis V Kalofonos, Haralabos P Fountzilas, George Dimopoulos, Meletios A Pavlidis, Nicholas Razis, Evangelia Economopoulos, Theofanis Pectasides, Dimitrios Gogas, Helen Kosmidis, Paris others
